Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 27916 AL 27930

The effect of animal assisted rehabilitation practices on symptoms of Alzheimer's patients: systematic review and meta-analysis

Tüzün Özdemir S, Özer S.

Geriatr Nurs. 2025 May-Jun;63:521-527. doi: 10.1016/j.gerinurse.2025.03.045. Epub 2025 Apr 24.

Wii Fit Exercise's Effects on Muscle Strength and Fear of Falling in Older Adults With Alzheimer Disease: A Randomized Controlled Trial

Uğur F, Sertel M.

J Aging Phys Act. 2024 Oct 7;33(2):181-191. doi: 10.1123/japa.2023-0428. Print 2025 Apr 1.

Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer 's disease: A systematic review and network meta- analysis

Cao W, Zhu B, Liu Z, Jia X, Zhao H, Gu N, Chang H, Xi J, Li R, Guo K, Shen J, Ding L, Sun F, Di Z.

Neuroscience. 2025 Jan 26;565:29-39. doi: 10.1016/j.neuroscience.2024.11.029. Epub 2024 Nov 15.

Detection of Alzheimer Disease in Neuroimages Using Vision Transformers: Systematic Review and Meta-Analysis

Mubonanyikuzo V, Yan H, Komolafe TE, Zhou L, Wu T, Wang N.

J Med Internet Res. 2025 Feb 5;27:e62647. doi: 10.2196/62647.

Alzheimer disease is (sometimes) highly heritable: Drivers of variation in heritability estimates for binary traits, a systematic review

Liu S, Bush WS, Akinyemi RO, Byrd GS, Caban-Holt AM, Rajabli F, Reitz C, Kunkle BW, Tosto G, Vance JM, Pericak-Vance M, Haines JL, Williams SM, Crawford DC.

PLoS Genet. 2025 Sep 4;21(9):e1011701. doi: 10.1371/journal.pgen.1011701. eCollection 2025 Sep.

Glutamatergic and GABAergic metabolite levels in Alzheimer's disease: a systematic review and meta-analysis

Ebrahimi R, Mohammad Soltani S, Masouri MM, Seifi M, Ghafourian K, Noori S.

BMC Neurol. 2025 Aug 26;25(1):344. doi: 10.1186/s12883-025-04375-2.

A multi-modal medical management and lifestyle intervention increase cerebral blood flow and lowers diabetic risk in persons with early Alzheimer's disease: Mid-trial results from the PREVENTION trial

Bramen JE, Siddarth P, Popa ES, Kress GT, Rapozo MK, Hodes JF, Ganapathi AS, Sparks WM, Tongson YM, Torres AM, Meysami S, Slyapich CB, Glatt RM, Pierce K, Miller KJ, Elhelou SH, Porter VR, Wong C, Kim M, Panos S, Hirsch DA, Raji CA, Bookheimer SY, Hood L, Roach JC, Merrill DA.

J Alzheimers Dis. 2025 Dec;108(4):1819-1833. doi: 10.1177/13872877251388933. Epub 2025 Nov 16.

Hippocampal Subfields Volume: Another Hint of the Continuum Between CAA and AD?

Storti B, Stanziano M, Marinoni G, Mazzè A, Francia A, Zacarias E, Strazzabosco C, De Toma C, Rifino N, Boncoraglio G, Di Fede G, Pollaci G, Gatti L, Canavero I, Bersano A.

Eur J Neurol. 2025 Jul;32(7):e70284. doi: 10.1111/ene.70284.

Therapeutic Efficacy of Autologous Blood-Derived Stem Cells with Growth Factors in Moderate to Severe Alzheimer's Disease: A Clinical Trial

Lee WJ, Cho K, Lee D, Lee S, Kim GW.

Mol Neurobiol. 2025 Dec 10;63(1):277. doi: 10.1007/s12035-025-05583-0.

Associations between selected genetic variants and lipid profile variability in response to statins in Alzheimer's disease: a prospective observational study

Oliveira FF, Almeida SS, Chen ES, Bertolucci PHF, Smith MC.

Sao Paulo Med J. 2025 Aug 15;143(4):e2024160. doi: 10.1590/1516-3180.2024.0160.27112024. eCollection 2025.

Safety and efficacy of transcranial ultrasound stimulation for the treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial

Fuh JL, Wang SJ, Wang PN, Wu HM, Su WS, Lin HM, Yang FY.

Ultrasonics. 2026 Mar;159:107844. doi: 10.1016/j.ultras.2025.107844. Epub 2025 Oct 3.

A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease

Fuseya K, Mimura Y, Nakajima S, Mimura M, Kasanuki K, Noda Y.

J Alzheimers Dis. 2025 May;105(1):28-43. doi: 10.1177/13872877251325887. Epub 2025 Mar 20.

Initial Real-World Evidence for Lecanemab in the United States

Brixner DI, Zhao C, Toyosaki H, Frech FH, Rosenbloom MH.

Drugs Aging. 2026 Jan;43(1):69-76. doi: 10.1007/s40266-025-01261-x. Epub 2025 Oct 29.

Telomere dynamics are influenced by sleep, sleep variability and circadian rhythms in older adults with or without alzheimer's risk

Lehodey A, Montagne B, Rehel S, Kaliman P, Chocat A, Mezenge F, Landeau B, de la Sayette V, Chételat G, Rauchs G, Poisnel G; Medit-Ageing Research Group.

Alzheimers Res Ther. 2025 Dec 5;18(1):10. doi: 10.1186/s13195-025-01923-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias